Betasag-FL-SR combines Flunarizine (10 mg) and Propranolol Hydrochloride (40 mg) in a sustained-release formulation, offering an effective solution for managing migraines and reducing headache frequency. Flunarizine, a calcium channel blocker, helps prevent migraine attacks by stabilizing blood vessel function, while Propranolol, a beta-blocker, reduces the severity and frequency of migraines. Together, they provide a comprehensive approach to migraine management, improving quality of life for patients suffering from this debilitating condition.






Reviews
There are no reviews yet.